Yin S - Search Results

1

Development of purification process for dual-function recombinant human heavy-chain ferritin by the investigation of genetic modification impact on conformation.

Yin S, Zhang B, Lin J, Liu Y, Su Z, Bi J. Yin S, et al. Eng Life Sci. 2021 Jun 19;21(10):630-642. doi: 10.1002/elsc.202000105. eCollection 2021 Oct. Eng Life Sci. 2021. PMID: 34690634 Free PMC article.

2

Cost-effective purification process development for chimeric hepatitis B core (HBc) virus-like particles assisted by molecular dynamic simulation.

Zhang B, Yin S, Wang Y, Su Z, Bi J. Zhang B, et al. Among authors: yin s. Eng Life Sci. 2021 May 3;21(6):438-452. doi: 10.1002/elsc.202000104. eCollection 2021 Jun. Eng Life Sci. 2021. PMID: 34140854 Free PMC article.

3

Extending Half Life of H-Ferritin Nanoparticle by Fusing Albumin Binding Domain for Doxorubicin Encapsulation.

Wang C, Zhang C, Li Z, Yin S, Wang Q, Guo F, Zhang Y, Yu R, Liu Y, Su Z. Wang C, et al. Among authors: yin s. Biomacromolecules. 2018 Mar 12;19(3):773-781. doi: 10.1021/acs.biomac.7b01545. Epub 2018 Feb 5. Biomacromolecules. 2018. PMID: 29328653

4

In vitro preparation of uniform and nucleic acid free hepatitis B core particles through an optimized disassembly-purification-reassembly process.

Zhang Y, Liu Y, Zhang B, Yin S, Li X, Zhao D, Wang W, Bi J, Su Z. Zhang Y, et al. Among authors: yin s. Protein Expr Purif. 2021 Feb;178:105747. doi: 10.1016/j.pep.2020.105747. Epub 2020 Sep 6. Protein Expr Purif. 2021. PMID: 32898688

5

Stability of Engineered Ferritin Nanovaccines Investigated by Combined Molecular Simulation and Experiments.

Qu Y, Wang L, Yin S, Zhang B, Jiao Y, Sun Y, Middelberg A, Bi J. Qu Y, et al. Among authors: yin s. J Phys Chem B. 2021 Apr 22;125(15):3830-3842. doi: 10.1021/acs.jpcb.1c00276. Epub 2021 Apr 7. J Phys Chem B. 2021. PMID: 33825471

6

Engineered Human Heavy-Chain Ferritin with Half-Life Extension and Tumor Targeting by PAS and RGDK Peptide Functionalization.

Yin S, Wang Y, Zhang B, Qu Y, Liu Y, Dai S, Zhang Y, Wang Y, Bi J. Yin S, et al. Pharmaceutics. 2021 Apr 9;13(4):521. doi: 10.3390/pharmaceutics13040521. Pharmaceutics. 2021. PMID: 33918853 Free PMC article.

7

Mechanism Study of Thermally Induced Anti-Tumor Drug Loading to Engineered Human Heavy-Chain Ferritin Nanocages Aided by Computational Analysis.

Yin S, Liu Y, Dai S, Zhang B, Qu Y, Zhang Y, Choe WS, Bi J. Yin S, et al. Biosensors (Basel). 2021 Nov 11;11(11):444. doi: 10.3390/bios11110444. Biosensors (Basel). 2021. PMID: 34821660 Free PMC article.

8

Immunogenicity and Vaccine Efficacy Boosted by Engineering Human Heavy Chain Ferritin and Chimeric Hepatitis B Virus Core Nanoparticles.

Qu Y, Zhang B, Wang Y, Yin S, Sun Y, Middelberg A, Bi J. Qu Y, et al. Among authors: yin s. ACS Appl Bio Mater. 2021 Sep 20;4(9):7147-7156. doi: 10.1021/acsabm.1c00738. Epub 2021 Sep 8. ACS Appl Bio Mater. 2021. PMID: 35006946

9

Albumin Binding Domain Fusing R/K-X-X-R/K Sequence for Enhancing Tumor Delivery of Doxorubicin.

Liu L, Zhang C, Li Z, Wang C, Bi J, Yin S, Wang Q, Yu R, Liu Y, Su Z. Liu L, et al. Among authors: yin s. Mol Pharm. 2017 Nov 6;14(11):3739-3749. doi: 10.1021/acs.molpharmaceut.7b00497. Epub 2017 Oct 9. Mol Pharm. 2017. PMID: 28950700

10

Immunogenicity study of engineered ferritins with C- and N-terminus insertion of Epstein-Barr nuclear antigen 1 epitope.

Qu Y, Zhang B, Wang Y, Yin S, Pederick JL, Bruning JB, Sun Y, Middelberg A, Bi J. Qu Y, et al. Among authors: yin s. Vaccine. 2021 Aug 9;39(34):4830-4841. doi: 10.1016/j.vaccine.2021.07.021. Epub 2021 Jul 18. Vaccine. 2021. PMID: 34284876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,524 results

Search Page

Filters